Delivery Order SPE2DB22D2007-SPE2DB24FH9QA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Thrombin-JMI 20,000 unit vials valued at $1,550.51. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Thrombin-JMI 5,000 unit vials. This competitively awarded, non-set-aside contract carries a ceiling value of $7,615.26 under a firm fixed-price delivery order arrangement, with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 5,000 Units Vials on April 23, 2025, with a ceiling value of $1,334.80. This competitively awarded, firm fixed price delivery order is scheduled for completion by April 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract involves no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,236.16 firm fixed-price contract is for the supply of 4,557,711,596 units of Thrombin-JMI, a 20,000-unit vial medication. The award was made on July 5, 2022, with a completion date of July 6, 2022. This contract is a task order under AmerisourceBergen's larger $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,765.48 firm fixed-price delivery order is for the supply of 20,000-unit vials of the drug Thrombin-JMI. The contract has an ultimate completion date of November 30, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of THROMBIN-JMI 20,000 UNITS VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 1, 2021, with a ceiling value of $13,799.82 and a completion date of September 2, 2021. The contract is a Delivery Order under a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,221.58 Firm Fixed Price delivery order covers the supply of 20,000 unit vials of Thrombin-JMI, a critical medication. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (parent company of Amerisourcebergen Drug Corp) holds with the DLA...
- The Defense Logistics Agency awarded a $7,174.28 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20,000 units of Thrombin-JMI vials. The single day order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility to support the Department of Defense's medical supply needs. No additional details were provided regarding the context or purpose of the ordered products. The award utilizes no set-aside designations and does not appear to be associated...
- <p>Amerisourcebergen Drug Corp has been awarded a six hundred forty-seven dollar firm fixed price delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency. The delivery order is for five thousand units of Thrombin-JMI five thousand units vials with an anticipated completion date of October 19, 2023. Performance will take place in Conshohocken, Pennsylvania. No set-aside designation was applied to this award.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical procedures. This firm fixed-price delivery order, valued at $4,839.49, represents a competitive award with no set-aside designation and is scheduled for completion by August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9QADelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of 20,000 unit vials of the pharmaceutical product THROMBIN-JMI, with a potential value of $1,852.50 and a completion date of February 15, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor, providing a wide range of pharmaceutical products and medical supplies to various U.S. government agencies, particularly the Department of Defense, through multiple indefinite delivery contracts. This delivery order is issued under one such indefinite delivery contract with DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 2/14/24 |